Kre-Alkalyn Compound

Brand IP Statement(s) re: (c), (TM), (SM)

Kre-Alkalyn is a patented product (US # 6,399,661) and registered trademark of All American Pharmaceutical. International patents pending.

Brand IP Statement(s) re: (c), (TM), (SM)

Kre-Alkalyn +Ph-Correct Creatine

FDA Disclaimer Statement

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

General Statements: All Other Content

The Science of Supplements: Evidencebasedformulary.net

General: Product/Version Code

V 1.0

Formula re: Contains

pH-Specific Creatin

General Statements: All Other Content

U.S. patent 6,399,661

General Statements: All Other Content

Lean muscle Endurance Strength -No loading -No bloating -Cell volumizer

FDA Statement of Identity

Dietary Supplement

Suggested/Recommended/Usage/Directions

Suggested use for adults only As a dietary supplement, take 1-2 capsules in the morning with water and take 1-2 capsules in the morning with water and take 1-2 capsules 30 minutes prior to physical activity. For maximum benefits, take an additional 1-2 capsules post workout as a recovery aid. Non-training days: Take 2 capsules with the first meal of the day.

Precautions re: Allergies

Allergen Warning: This product was produced in a facility that may also process ingredients containing milk, egg, soybeans, shellfish, fish, tree nuts, and peanuts.

General Statements: All Other Content

Put the science in your gym bag. One of the first patented creatines introduced in 2000.

Brand IP Statement(s) re: (c), (TM), (SM)

Kre-Alkalyn continues to be a dominant force in the creatine market.

General Statements: All Other Content

Biorhythm’s Kre-Alkalyn Compound has taken over a decade of proven results and pushed this skin stretching gainer even further.

Formula re: Contains

The advanced creatine formula is spiked with Alpha Lipoic Acid, Vanadyl Sulfate and Chromium Picolinate to enhance absorption, support blood glucose and promote intense vascularity.

General Statements: All Other Content

Evidence based formulary